EdgarLookup

ALX ONCOLOGY HOLDINGS INC — 8-K Filings

57 8-K filings on record

This page lists all 8-K filings submitted to the SEC by ALX ONCOLOGY HOLDINGS INC (ALXO), sorted by most recent first. Each row links to the full filing on EdgarLookup. ALX ONCOLOGY HOLDINGS INC has filed 57 8-K documents with the SEC since 2020. To view all SEC filings by ALX ONCOLOGY HOLDINGS INC, see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 3 3/A 4 4/A 424B3 424B4 424B5 8-A12B 8-K ARS CERT CORRESP DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT POS AM S-1 S-1/A S-1MEF S-3 S-3/A S-3ASR S-8 SC 13D SC 13D/A SC 13G SC 13G/A SC TO-I SC TO-I/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
8-K 8-K 0001193125-26-079342 Feb 27, 2026
8-K 8-K 0001193125-26-030579 Jan 30, 2026
8-K 8-K 0001193125-26-030561 Jan 30, 2026
8-K 8-K 0001193125-26-018094 Jan 21, 2026
8-K 8-K 0001193125-25-271112 Nov 7, 2025
8-K 8-K 0001810182-25-000006 Sep 12, 2025 Sep 11, 2025
8-K 8-K 0000950170-25-107277 Aug 12, 2025
8-K 8-K 0000950170-25-085364 Jun 12, 2025 Jun 11, 2025
8-K 8-K 0000950170-25-066440 May 8, 2025
8-K 8-K 0000950170-25-058687 Apr 25, 2025 Apr 23, 2025
8-K 8-K 0000950170-25-034574 Mar 6, 2025
8-K 8-K 0000950170-25-033504 Mar 5, 2025 Feb 28, 2025
8-K 8-K 0000950170-25-007532 Jan 22, 2025 Jan 16, 2025
8-K 8-K 0001193125-25-008461 Jan 17, 2025 Jan 16, 2025
8-K 8-K 0000950170-24-126749 Nov 14, 2024 Nov 8, 2024
8-K 8-K 0000950170-24-123252 Nov 7, 2024 Nov 5, 2024
8-K 8-K 0000950170-24-112734 Oct 4, 2024 Sep 30, 2024
8-K 8-K 0000950170-24-093930 Aug 8, 2024
8-K 8-K 0000950170-24-091938 Aug 6, 2024 Aug 5, 2024
8-K 8-K 0000950170-24-074258 Jun 17, 2024 Jun 12, 2024
8-K 8-K 0000950170-24-056886 May 9, 2024
8-K 8-K 0000950170-24-052093 May 2, 2024 Apr 28, 2024
8-K 8-K 0000950170-24-027925 Mar 7, 2024
8-K 8-K 0000950170-23-073016 Dec 26, 2023 Dec 22, 2023
8-K 8-K 0000950170-23-062903 Nov 13, 2023
8-K 8-K 0001193125-23-251917 Oct 6, 2023 Oct 4, 2023
8-K 8-K 0001193125-23-250822 Oct 4, 2023
8-K 8-K 0001193125-23-250357 Oct 4, 2023 Oct 3, 2023
8-K 8-K 0001193125-23-229584 Sep 6, 2023 Sep 1, 2023
8-K 8-K 0000950170-23-041287 Aug 10, 2023
8-K 8-K 0000950170-23-028787 Jun 20, 2023 Jun 16, 2023
8-K 8-K 0000950170-23-021199 May 11, 2023
8-K 8-K 0001193125-23-068511 Mar 13, 2023 Mar 10, 2023
8-K 8-K 0000950170-23-006999 Mar 9, 2023
8-K 8-K 0000950170-22-025765 Nov 29, 2022 Nov 28, 2022
8-K 8-K 0000950170-22-023194 Nov 8, 2022
8-K 8-K 0000950170-22-020521 Oct 31, 2022 Oct 27, 2022
8-K 8-K 0000950170-22-015504 Aug 8, 2022
8-K 8-K 0001193125-22-175515 Jun 16, 2022 Jun 14, 2022
8-K 8-K 0000950170-22-008477 May 9, 2022
8-K 8-K 0000950170-22-005597 Apr 12, 2022 Apr 11, 2022
8-K Q4'21 8-K/PR 0001564590-22-007361 Feb 28, 2022
8-K 8-K 0001193125-21-361275 Dec 17, 2021
8-K Q3'21 8-K 0001564590-21-056507 Nov 12, 2021 Nov 11, 2021
8-K SCALMIBIO ACQUISITION 0001564590-21-050370 Oct 7, 2021 Oct 4, 2021
8-K 8-K 0001564590-21-046136 Aug 27, 2021 Aug 26, 2021
8-K 8-K 0001564590-21-043991 Aug 12, 2021
8-K 8-K 0001564590-21-033029 Jun 15, 2021 Jun 10, 2021
8-K 8-K 0001564590-21-028385 May 17, 2021
8-K 8-K 0001564590-21-023431 May 4, 2021 May 3, 2021